Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 109Active not recruiting 58Not yet recruiting 20Completed 19Terminated 7Enrolling by invitation 6Withdrawn 1Suspended 1Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 6Thoracic 4Other hematologic neoplasm 3Lymphoid 3Tumor-Agnostic 2Plasma cell 2Gastrointestinal 2Other solid neoplasm 1Head & Neck 1Gynecologic 1Dermatologic 1Breast 1

Conditions

Tinnitus 1Ototoxicity 1Lung Neoplasms 1Hearing Loss 1Head and Neck Neoplasms 1Deafness 1

Interventions

ebselen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Head & Neck × 30 days × Clear all
NCT01451853 2026-06-03

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Sound Pharmaceuticals, Incorporated

Phase 2 Withdrawn
Head & NeckThoracic

Ototoxicity, Deafness, Head and Neck Neoplasms, Lung Neoplasms, Tinnitus, Hearing Loss

Data powered by HemOnc (CC BY 4.0) Colophon âš¡